Register by 9/16 & Save 20% off the standard rates | | » Register Online | » View Pricing Register by Phone: 800.390.4078 Use Priority Code, B11171BROE to save off the standard rates. |  |  | Free Online Presentations Download | | To give you sneak peek at the caliber of the content presented at BioProcess International - we would like to give you FREE access to a few of our 2010 Keynote and Featured Presentations. Download Presentations |  |  | | | |  |  | Agenda | | » View the Online Agenda & Session Descriptions |  |  | Interested in Sending a Group? | | Take advantage our discounted rates for companies sending groups of 3 or more. For more information, contact 646-895-7445. |  | Can't Attend the Conference? But You Want to Visit the Exhibit Hall? | | Exhibit Hall & Keynote Passes are now available. Enter priority code B11171BROE when your Register by October 26th & Your Exhibit Hall & Keynote Pass will be FREE! |  | Join the Conversation on LinkedIn | | Join our LinkedIn Group: BioProcessing Professionals. | |  |  |  | BioProcess International is your one stop industry resource for driving down costs, improving quality, achieving rapid, robust and resilient process development and manufacturing. This conference is where challenges are explored, solutions are uncovered and opportunities are developed - and it is the largest and most highly respected event solely dedicated to biopharmaceutical manufacturing. This year the conference features over 50 presentations with new, previously unpublished data - plus many more to choose from, including keynote presentations touch upon topics from biosimilars to the industry's future direction. Keynote Presentations | Overview of Approval Pathway under Biologics Price Competition and Innovation Act of 2009 Steven Kozlowski, M.D. Director, Office of Biotechnology Products, OPS, CDER, US FDA |  | Bioprocess Technology & Innovation: Strategic Imperative for Challenging Times Timothy S. Charlebois, Ph.D. Vice President, Technology and Innovation Strategy, Pfizer |  | | EMA Draft Guideline on Biosimilar Monoclonal Antibodies Esa Heinonen, M.D., Ph.D. Member of the EMA Working Group on Biosimilars , Head of Section 2, Marketing Authorizations, Finnish Medicines Agency (Fimea), Finland |  | The International Chinese Hamster Ovary Genome Project: Where Do We Go from Here? Michael Betenbaugh, Ph.D. Professor, Chemical and Biomolecular Engineering, Johns Hopkins University |  | | Ready or not Biosimilars are Coming to US Jay S. Stout, Ph.D. Executive Director, Biologics Manufacturing Sciences and Commercialization, Merck & Co., Inc. |  | The Impact of Antibody Drug Conjugates on Process Development and Manufacturing Morris Rosenberg, Ph.D. Executive Vice President, Process Sciences, Seattle Genetics |  | | Integrating Two Biologics Manufacturing Networks Tim Moore Senior Vice President, Global Head, Pharmaceutical Technical Operations Biologics, Roche |  | Fitting the Glass Slipper: Process Design, Plant Capacity, and Value Realization Jeffrey C. Baker, Ph.D. Deputy Director, Office of Biotechnology Products (OBP), Center for Drug Evaluation and Research, U.S. FDA |  | | Vac to the Future: Vaccines Bioprocessing and Development John G. Aunins, Ph.D. Executive Scientific Director, Merck Research Laboratories |  | Public-Private Partnering for National Security & Public Health Needs Robin A. Robinson, Ph.D. ASPR Deputy Assistant Secretary and BARDA Director, US Department of Health and Human Services | With all these opportunities for gaining new knowledge, meeting new people and having important discussions about the future of the industry, you or someone from your team cannot afford to miss the 2011 conference! |